LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 36

Search options

  1. Article ; Online: Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.

    Mulato, Andrew / Lansdon, Eric / Aoyama, Ron / Voigt, Johannes / Lee, Michael / Liclican, Albert / Lee, Gary / Singer, Eric / Stafford, Brian / Gong, Ruoyu / Murray, Bernard / Chan, Julie / Lee, Johnny / Xu, Yili / Ahmadyar, Shekeba / Gonzalez, Ana / Cho, Aesop / Stepan, George J / Schmitz, Uli /
    Schultz, Brian / Marchand, Bruno / Brumshtein, Boris / Wang, Ruth / Yu, Helen / Cihlar, Tomas / Xu, Lianhong / Yant, Stephen R

    Antimicrobial agents and chemotherapy

    2024  Volume 68, Issue 4, Page(s) e0137323

    Abstract: Protease inhibitors (PIs) remain an important component of antiretroviral therapy for the treatment of HIV-1 infection due to their high genetic barrier to resistance development. Nevertheless, the two most commonly prescribed HIV PIs, atazanavir and ... ...

    Abstract Protease inhibitors (PIs) remain an important component of antiretroviral therapy for the treatment of HIV-1 infection due to their high genetic barrier to resistance development. Nevertheless, the two most commonly prescribed HIV PIs, atazanavir and darunavir, still require co-administration with a pharmacokinetic boosting agent to maintain sufficient drug plasma levels which can lead to undesirable drug-drug interactions. Herein, we describe GS-9770, a novel investigational non-peptidomimetic HIV PI with unboosted once-daily oral dosing potential due to improvements in its metabolic stability and its pharmacokinetic properties in preclinical animal species. This compound demonstrates potent inhibitory activity and high on-target selectivity for recombinant HIV-1 protease versus other aspartic proteases tested. In cell culture, GS-9770 inhibits Gag polyprotein cleavage and shows nanomolar anti-HIV-1 potency in primary human cells permissive to HIV-1 infection and against a broad range of HIV subtypes. GS-9770 demonstrates an improved resistance profile against a panel of patient-derived HIV-1 isolates with resistance to atazanavir and darunavir. In resistance selection experiments, GS-9770 prevented the emergence of breakthrough HIV-1 variants at all fixed drug concentrations tested and required multiple protease substitutions to enable outgrowth of virus exposed to escalating concentrations of GS-9770. This compound also remained fully active against viruses resistant to drugs from other antiviral classes and showed no
    MeSH term(s) Humans ; HIV Protease Inhibitors/pharmacology ; HIV Protease Inhibitors/therapeutic use ; Darunavir/pharmacology ; Darunavir/therapeutic use ; Atazanavir Sulfate/pharmacology ; Atazanavir Sulfate/therapeutic use ; Drug Resistance, Viral ; HIV-1/genetics ; Anti-Retroviral Agents/therapeutic use ; HIV Infections/drug therapy ; HIV Protease/genetics ; HIV Protease/metabolism
    Chemical Substances HIV Protease Inhibitors ; Darunavir (YO603Y8113) ; Atazanavir Sulfate (4MT4VIE29P) ; Anti-Retroviral Agents ; HIV Protease (EC 3.4.23.-)
    Language English
    Publishing date 2024-02-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.01373-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus Treatment.

    Feng, Joy Y / Wang, Ting / Park, Yeojin / Babusis, Darius / Birkus, Gabriel / Xu, Yili / Voitenleitner, Christian / Fenaux, Martijn / Yang, Huiling / Eng, Stacey / Tirunagari, Neeraj / Kirschberg, Thorsten / Cho, Aesop / Ray, Adrian S

    Antimicrobial agents and chemotherapy

    2018  Volume 62, Issue 8

    Abstract: Delivery of pharmacologically active nucleoside triphosphate analogs to sites of viral infection is challenging. In prior work we identified a 2'- ...

    Abstract Delivery of pharmacologically active nucleoside triphosphate analogs to sites of viral infection is challenging. In prior work we identified a 2'-
    MeSH term(s) Administration, Oral ; Animals ; Antiviral Agents/administration & dosage ; Antiviral Agents/pharmacokinetics ; Antiviral Agents/therapeutic use ; Caco-2 Cells ; Cells, Cultured ; Dogs ; Hepacivirus/drug effects ; Hepacivirus/pathogenicity ; Hepatitis C/virology ; Humans ; Male ; Nucleotides/administration & dosage ; Nucleotides/pharmacokinetics ; Nucleotides/therapeutic use ; Prodrugs/administration & dosage ; Prodrugs/pharmacokinetics ; Prodrugs/therapeutic use ; Rats ; Triazines/administration & dosage ; Triazines/pharmacokinetics ; Triazines/therapeutic use ; Virus Replication/drug effects
    Chemical Substances Antiviral Agents ; Nucleotides ; Prodrugs ; Triazines ; GS-6620 (WD5DUG7X38)
    Language English
    Publishing date 2018-07-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.00620-18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Practical synthesis of 1′-substituted Tubercidin C-nucleoside analogs

    Metobo, Sammy E / Xu, Jie / Saunders, Oliver L / Butler, Thomas / Aktoudianakis, Evangelos / Cho, Aesop / Kim, Choung U

    Tetrahedron letters. 2012 Feb. 1, v. 53, no. 5

    2012  

    Abstract: Several 1′-substituted analogs of Tubercidin C-nucleosides were prepared using a highly convergent synthesis. Good to high diastereoselectivity was achieved using a variety of nucleophiles targeting the 1′-position. The source for this stereoselectivity ... ...

    Abstract Several 1′-substituted analogs of Tubercidin C-nucleosides were prepared using a highly convergent synthesis. Good to high diastereoselectivity was achieved using a variety of nucleophiles targeting the 1′-position. The source for this stereoselectivity is herein proposed. It is thought to be attributed to a temperature-dependent chelation of the incoming nucleophile to either the 2′- or 3′-benzyloxy ether of the ribose core.
    Keywords chelation ; chemical structure ; organic compounds ; ribose ; synthesis
    Language English
    Dates of publication 2012-0201
    Size p. 484-486.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 204287-3
    ISSN 1873-3581 ; 0040-4039
    ISSN (online) 1873-3581
    ISSN 0040-4039
    DOI 10.1016/j.tetlet.2011.11.055
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Synthesis and characterization of 1'-C-cyano-2'-fluoro-2'-C-methyl pyrimidine nucleosides as HCV polymerase inhibitors.

    Kirschberg, Thorsten A / Mish, Michael R / Zhang, Lijun / Squires, Neil H / Wang, Ke-Yu / Cho, Aesop / Feng, Joy Y / Fenaux, Martijn / Babusis, Darius / Park, Yeojin / Ray, Adrian S / Kim, Choung U

    Bioorganic & medicinal chemistry letters

    2015  Volume 25, Issue 5, Page(s) 1040–1043

    Abstract: The first synthesis of 1'-C-CN, 2'-F, 2'-C-Me pyrimidines is described. Anti-HCV activity was assessed and compared to the 1'-C-CN, 2'-C-Me as well as the 2'-F, 2'-C-Me pyrimidines. A phosphoramidate prodrug of the cytidine derivative showed activity in ... ...

    Abstract The first synthesis of 1'-C-CN, 2'-F, 2'-C-Me pyrimidines is described. Anti-HCV activity was assessed and compared to the 1'-C-CN, 2'-C-Me as well as the 2'-F, 2'-C-Me pyrimidines. A phosphoramidate prodrug of the cytidine derivative showed activity in the low micromolar range against HCV replicons.
    MeSH term(s) Amides/chemistry ; Amides/pharmacology ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Cell Line ; Halogenation ; Hepacivirus/drug effects ; Hepacivirus/enzymology ; Hepatitis C/drug therapy ; Hepatitis C/virology ; Humans ; Methylation ; Phosphoric Acids/chemistry ; Phosphoric Acids/pharmacology ; Prodrugs/chemistry ; Prodrugs/pharmacology ; Pyrimidine Nucleosides/chemistry ; Pyrimidine Nucleosides/pharmacology ; RNA Replicase/antagonists & inhibitors ; Replicon/drug effects
    Chemical Substances Amides ; Antiviral Agents ; Phosphoric Acids ; Prodrugs ; Pyrimidine Nucleosides ; phosphoramidic acid (9Q189608GB) ; RNA Replicase (EC 2.7.7.48)
    Language English
    Publishing date 2015-03-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2015.01.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Synthesis of 1'-C-cyano pyrimidine nucleosides and characterization as HCV polymerase inhibitors.

    Kirschberg, Thorsten A / Mish, Michael / Squires, Neil H / Zonte, Sebastian / Aktoudianakis, Evangelos / Metobo, Sammy / Butler, Thomas / Ju, Xie / Cho, Aesop / Ray, Adrian S / Kim, Choung U

    Nucleosides, nucleotides & nucleic acids

    2015  Volume 34, Issue 11, Page(s) 763–785

    Abstract: Ribose modified 1'-C-cyano pyrimidine nucleosides were synthesized. A silver triflate mediated Vorbrüggen reaction was used to generate the nucleoside scaffold and follow-up chemistry provided specific ribose modified analogs. Nucleosides and ... ...

    Abstract Ribose modified 1'-C-cyano pyrimidine nucleosides were synthesized. A silver triflate mediated Vorbrüggen reaction was used to generate the nucleoside scaffold and follow-up chemistry provided specific ribose modified analogs. Nucleosides and phosphoramidate prodrugs were tested for their anti-HCV activity.
    MeSH term(s) Chemistry Techniques, Synthetic ; DNA-Directed RNA Polymerases/antagonists & inhibitors ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Hepacivirus/enzymology ; Pyrimidine Nucleosides/chemical synthesis ; Pyrimidine Nucleosides/chemistry ; Pyrimidine Nucleosides/pharmacology
    Chemical Substances Enzyme Inhibitors ; Pyrimidine Nucleosides ; DNA-Directed RNA Polymerases (EC 2.7.7.6)
    Language English
    Publishing date 2015
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2008956-9
    ISSN 1532-2335 ; 1525-7770
    ISSN (online) 1532-2335
    ISSN 1525-7770
    DOI 10.1080/15257770.2015.1075550
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides

    Cho, Aesop / Saunders, Oliver L / Butler, Thomas / Zhang, Lijun / Xu, Jie / Vela, Jennifer E / Feng, Joy Y / Ray, Adrian S / Kim, Choung U

    Bioorganic & medicinal chemistry letters. 2012 Apr. 15, v. 22, no. 8

    2012  

    Abstract: A series of 1′-substituted analogs of 4-aza-7,9-dideazaadenosine C-nucleoside were prepared and evaluated for the potential as antiviral agents. These compounds showed a broad range of inhibitory activity against various RNA viruses. In particular, the ... ...

    Abstract A series of 1′-substituted analogs of 4-aza-7,9-dideazaadenosine C-nucleoside were prepared and evaluated for the potential as antiviral agents. These compounds showed a broad range of inhibitory activity against various RNA viruses. In particular, the whole cell potency against HCV when R=CN was attributed to inhibition of HCV NS5B polymerase and intracellular concentration of the corresponding nucleoside triphosphate.
    Keywords RNA ; antiviral agents ; antiviral properties ; chemistry ; nucleoside-triphosphate phosphatase ; viruses ; covid19
    Language English
    Dates of publication 2012-0415
    Size p. 2705-2707.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2012.02.105
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article: Synthesis of 1-amino-2-vinylcyclopropane-1-phosphinates. Conversion of a phosphonate to phosphinates

    Pyun, Hyung-Jung / Clarke, Michael O / Cho, Aesop / Casarez, Anthony / Ji, Mingzhe / Fardis, Maria / Pastor, Richard / Sheng, X. Christopher / Kim, Choung U

    Tetrahedron letters. 2012 May 2, v. 53, no. 18

    2012  

    Abstract: Conversion of diethyl 1-amino-2-vinylcyclopropanephosphonate to ethyl 1-amino-2-vinylcyclopropanephosphinate was accomplished by using either nucleophilic or electrophilic carbon reagents. Hydrolysis of the phosphonate diethyl ester to the mono acid ... ...

    Abstract Conversion of diethyl 1-amino-2-vinylcyclopropanephosphonate to ethyl 1-amino-2-vinylcyclopropanephosphinate was accomplished by using either nucleophilic or electrophilic carbon reagents. Hydrolysis of the phosphonate diethyl ester to the mono acid followed by oxalyl chloride treatment provided the phosphonomonochloridate, which was treated with nucleophilic organometallic agents to afford phosphinate ethyl esters. Alternatively, the chloridate was reduced to the phosphonous ethyl ester, and then alkylated with various electrophilic alkylating agents to obtain phosphinate ethyl esters.
    Keywords carbon ; chemical structure ; esters ; hydrolysis ; synthesis
    Language English
    Dates of publication 2012-0502
    Size p. 2360-2363.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 204287-3
    ISSN 1873-3581 ; 0040-4039
    ISSN (online) 1873-3581
    ISSN 0040-4039
    DOI 10.1016/j.tetlet.2012.02.111
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.

    Mish, Michael R / Cho, Aesop / Kirschberg, Thorsten / Xu, Jie / Zonte, C Sebastian / Fenaux, Martijn / Park, Yeojin / Babusis, Darius / Feng, Joy Y / Ray, Adrian S / Kim, Choung U

    Bioorganic & medicinal chemistry letters

    2014  Volume 24, Issue 14, Page(s) 3092–3095

    Abstract: The first synthesis of 1'-cyano-2'-C-methyl pyrimidine nucleosides is described. Anti-HCV activity of these nucleosides and their nucleotide phosphoramidate prodrugs was assessed and compared to the 1'-unsubstituted counterparts and to the related 1'- ... ...

    Abstract The first synthesis of 1'-cyano-2'-C-methyl pyrimidine nucleosides is described. Anti-HCV activity of these nucleosides and their nucleotide phosphoramidate prodrugs was assessed and compared to the 1'-unsubstituted counterparts and to the related 1'-cyano-2'-C-methyl C-nucleoside parent of GS-6620.
    MeSH term(s) Antiviral Agents/chemical synthesis ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Hepacivirus/drug effects ; Hepacivirus/enzymology ; Microbial Sensitivity Tests ; Molecular Conformation ; Nucleosides/chemical synthesis ; Nucleosides/chemistry ; Nucleosides/pharmacology ; Pyrimidine Nucleosides/chemical synthesis ; Pyrimidine Nucleosides/chemistry ; Pyrimidine Nucleosides/pharmacology ; RNA-Dependent RNA Polymerase/antagonists & inhibitors ; RNA-Dependent RNA Polymerase/metabolism ; Structure-Activity Relationship ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Nonstructural Proteins/metabolism
    Chemical Substances Antiviral Agents ; Enzyme Inhibitors ; Nucleosides ; Pyrimidine Nucleosides ; Viral Nonstructural Proteins ; NS-5 protein, hepatitis C virus (EC 2.7.7.48) ; RNA-Dependent RNA Polymerase (EC 2.7.7.48)
    Language English
    Publishing date 2014-05-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2014.05.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase.

    Appleby, Todd C / Perry, Jason K / Murakami, Eisuke / Barauskas, Ona / Feng, Joy / Cho, Aesop / Fox, David / Wetmore, Diana R / McGrath, Mary E / Ray, Adrian S / Sofia, Michael J / Swaminathan, S / Edwards, Thomas E

    Science (New York, N.Y.)

    2014  Volume 347, Issue 6223, Page(s) 771–775

    Abstract: Nucleotide analog inhibitors have shown clinical success in the treatment of hepatitis C virus (HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-dependent RNA polymerase. Here we study the details of HCV RNA ... ...

    Abstract Nucleotide analog inhibitors have shown clinical success in the treatment of hepatitis C virus (HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-dependent RNA polymerase. Here we study the details of HCV RNA replication by determining crystal structures of stalled polymerase ternary complexes with enzymes, RNA templates, RNA primers, incoming nucleotides, and catalytic metal ions during both primed initiation and elongation of RNA synthesis. Our analysis revealed that highly conserved active-site residues in NS5B position the primer for in-line attack on the incoming nucleotide. A β loop and a C-terminal membrane-anchoring linker occlude the active-site cavity in the apo state, retract in the primed initiation assembly to enforce replication of the HCV genome from the 3' terminus, and vacate the active-site cavity during elongation. We investigated the incorporation of nucleotide analog inhibitors, including the clinically active metabolite formed by sofosbuvir, to elucidate key molecular interactions in the active site.
    MeSH term(s) Amino Acid Sequence ; Catalytic Domain ; Conserved Sequence ; Crystallography, X-Ray ; Hepacivirus/enzymology ; Hepacivirus/genetics ; Hepacivirus/physiology ; Molecular Sequence Data ; Protein Structure, Secondary ; RNA, Viral/biosynthesis ; RNA-Dependent RNA Polymerase/chemistry ; Ribonucleotides/chemistry ; Sofosbuvir ; Uridine Monophosphate/analogs & derivatives ; Uridine Monophosphate/chemistry ; Viral Nonstructural Proteins/chemistry ; Virus Replication
    Chemical Substances RNA, Viral ; Ribonucleotides ; Viral Nonstructural Proteins ; Uridine Monophosphate (E2OU15WN0N) ; NS-5 protein, hepatitis C virus (EC 2.7.7.48) ; RNA-Dependent RNA Polymerase (EC 2.7.7.48) ; Sofosbuvir (WJ6CA3ZU8B)
    Language English
    Publishing date 2014-11-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.1259210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Metabolism and pharmacokinetics of the anti-hepatitis C virus nucleotide prodrug GS-6620.

    Murakami, Eisuke / Wang, Ting / Babusis, Darius / Lepist, Eve-Irene / Sauer, Dorothea / Park, Yeojin / Vela, Jennifer E / Shih, Robert / Birkus, Gabriel / Stefanidis, Dimitrios / Kim, Choung U / Cho, Aesop / Ray, Adrian S

    Antimicrobial agents and chemotherapy

    2014  Volume 58, Issue 4, Page(s) 1943–1951

    Abstract: The anti-hepatitis C virus nucleotide prodrug GS-6620 employs a double-prodrug approach, with l-alanine-isopropyl ester and phenol moieties attached to the 5'-phosphate that release the nucleoside monophosphate in hepatocytes and a 3'-isobutyryl ester ... ...

    Abstract The anti-hepatitis C virus nucleotide prodrug GS-6620 employs a double-prodrug approach, with l-alanine-isopropyl ester and phenol moieties attached to the 5'-phosphate that release the nucleoside monophosphate in hepatocytes and a 3'-isobutyryl ester added to improve permeability and oral bioavailability. Consistent with the stability found in intestinal homogenates, following oral administration, intact prodrug levels in blood plasma were the highest in dogs, followed by monkeys, and then were the lowest in hamsters. In contrast, liver levels of the triphosphate metabolite at the equivalent surface area-adjusted doses were highest in hamsters, followed by in dogs and monkeys. Studies in isolated primary hepatocytes suggest that relatively poor oral absorption in hamsters and monkeys was compensated for by relatively efficient hepatocyte activation. As intestinal absorption was found to be critical to the effectiveness of GS-6620 in nonclinical species, stomach pH, formulation, and food effect studies were completed in dogs. Consistent with in vitro absorption studies in Caco-2 cells, the absorption of GS-6620 was found to be complex and highly dependent on concentration. Higher rates of metabolism were observed at lower concentrations that were unable to saturate intestinal efflux transporters. In first-in-human clinical trials, the oral administration of GS-6620 resulted in poor plasma exposure relative to that observed in dogs and in large pharmacokinetic and pharmacodynamic variabilities. While a double-prodrug approach, including a 3'-isobutyryl ester, provided higher intrinsic intestinal permeability, this substitution appeared to be a metabolic liability, resulting in extensive intestinal metabolism and relatively poor oral absorption in humans.
    MeSH term(s) Administration, Oral ; Animals ; Antiviral Agents/pharmacokinetics ; Antiviral Agents/pharmacology ; Caco-2 Cells ; Cell Line ; Cricetinae ; Dogs ; Hepacivirus/drug effects ; Humans ; Macaca fascicularis ; Male ; Mesocricetus ; Prodrugs/pharmacokinetics ; Prodrugs/pharmacology
    Chemical Substances Antiviral Agents ; Prodrugs
    Language English
    Publishing date 2014-01-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.02350-13
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top